MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2021

MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair

Judit Serrat
Alexander Marc Thouin
Jacqueline Jacobs

Résumé

MAD2L2 (REV7) plays an important role in DNA double-strand break repair. As a member of the shieldin complex, consisting of MAD2L2, SHLD1, SHLD2 and SHLD3, it controls DNA repair pathway choice by counteracting DNA end-resection. Here we investigated the requirements for shieldin complex assembly and activity. Besides a dimerization-surface, HORMA-domain protein MAD2L2 has the extraordinary ability to wrap its C-terminus around SHLD3, likely creating a very stable complex. We show that appropriate function of MAD2L2 within shieldin requires its dimerization, mediated by SHLD2 and accelerating MAD2L2-SHLD3 interaction. Dimerization-defective MAD2L2 impairs shieldin assembly and fails to promote NHEJ. Moreover, MAD2L2 dimerization, along with the presence of SHLD3, allows shieldin to interact with the TRIP13 ATPase, known to drive topological switches in HORMA-domain proteins. We find that appropriate levels of TRIP13 are important for proper shieldin (dis)assembly and activity in DNA repair. Together our data provide important insights in the dependencies for shieldin activity.
Fichier principal
Vignette du fichier
s41467-021-25724-y(1).pdf (2.3 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03512353 , version 1 (11-01-2022)

Licence

Identifiants

Citer

Inge de Krijger, Bastian Föhr, Santiago Hernández Pérez, Estelle Vincendeau, Judit Serrat, et al.. MAD2L2 dimerization and TRIP13 control shieldin activity in DNA repair. Nature Communications, 2021, 12 (1), pp.5421. ⟨10.1038/s41467-021-25724-y⟩. ⟨hal-03512353⟩

Collections

INSERM PASTEUR
31 Consultations
26 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More